Logo image of JBTM

JBT MAREL CORP (JBTM) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:JBTM - US4778391049 - Common Stock

139.09 USD
+0.12 (+0.09%)
Last: 11/24/2025, 8:05:50 PM
139.09 USD
0 (0%)
After Hours: 11/24/2025, 8:05:50 PM
Fundamental Rating

3

Overall JBTM gets a fundamental rating of 3 out of 10. We evaluated JBTM against 130 industry peers in the Machinery industry. JBTM has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, JBTM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

JBTM had positive earnings in the past year.
JBTM had a positive operating cash flow in the past year.
In the past 5 years JBTM has always been profitable.
JBTM had a positive operating cash flow in each of the past 5 years.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

With a Return On Assets value of -1.35%, JBTM is not doing good in the industry: 71.54% of the companies in the same industry are doing better.
JBTM has a worse Return On Equity (-2.50%) than 71.54% of its industry peers.
JBTM's Return On Invested Capital of 1.95% is on the low side compared to the rest of the industry. JBTM is outperformed by 69.23% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for JBTM is below the industry average of 10.34%.
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROIC 1.95%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Profit Margin of JBTM has declined.
The Operating Margin of JBTM (4.81%) is worse than 62.31% of its industry peers.
In the last couple of years the Operating Margin of JBTM has declined.
JBTM has a better Gross Margin (35.80%) than 66.15% of its industry peers.
JBTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.81%
PM (TTM) N/A
GM 35.8%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBTM is destroying value.
JBTM has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for JBTM has been increased compared to 5 years ago.
JBTM has a worse debt/assets ratio than last year.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 1.83 indicates that JBTM is not a great score, but indicates only limited risk for bankruptcy at the moment.
JBTM has a Altman-Z score of 1.83. This is in the lower half of the industry: JBTM underperforms 67.69% of its industry peers.
JBTM has a debt to FCF ratio of 6.97. This is a slightly negative value and a sign of low solvency as JBTM would need 6.97 years to pay back of all of its debts.
JBTM has a Debt to FCF ratio (6.97) which is in line with its industry peers.
A Debt/Equity ratio of 0.43 indicates that JBTM is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.43, JBTM perfoms like the industry average, outperforming 53.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Altman-Z 1.83
ROIC/WACC0.22
WACC8.89%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

JBTM has a Current Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of JBTM (0.93) is worse than 90.00% of its industry peers.
A Quick Ratio of 0.53 indicates that JBTM may have some problems paying its short term obligations.
JBTM's Quick ratio of 0.53 is on the low side compared to the rest of the industry. JBTM is outperformed by 90.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.08% over the past year.
Measured over the past 5 years, JBTM shows a small growth in Earnings Per Share. The EPS has been growing by 0.52% on average per year.
Looking at the last year, JBTM shows a very strong growth in Revenue. The Revenue has grown by 92.43%.
JBTM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.48% yearly.
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%

3.2 Future

The Earnings Per Share is expected to grow by 22.75% on average over the next years. This is a very strong growth
Based on estimates for the next years, JBTM will show a small growth in Revenue. The Revenue will grow by 4.83% on average per year.
EPS Next Y17.72%
EPS Next 2Y21.12%
EPS Next 3Y22.75%
EPS Next 5YN/A
Revenue Next Year113.32%
Revenue Next 2Y49.55%
Revenue Next 3Y33%
Revenue Next 5Y4.83%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.80, JBTM is valued on the expensive side.
JBTM's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of JBTM to the average of the S&P500 Index (25.65), we can say JBTM is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 18.59, the valuation of JBTM can be described as rather expensive.
JBTM's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.45, JBTM is valued a bit cheaper.
Industry RankSector Rank
PE 22.8
Fwd PE 18.59
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.38% of the companies in the same industry are cheaper than JBTM, based on the Enterprise Value to EBITDA ratio.
JBTM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.43
EV/EBITDA 22.77
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as JBTM's earnings are expected to grow with 22.75% in the coming years.
PEG (NY)1.29
PEG (5Y)44.04
EPS Next 2Y21.12%
EPS Next 3Y22.75%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.30%, JBTM is not a good candidate for dividend investing.
JBTM's Dividend Yield is comparable with the industry average which is at 1.97.
With a Dividend Yield of 0.30, JBTM pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 0.3%

5.2 History

The dividend of JBTM has a limited annual growth rate of 0.48%.
JBTM has been paying a dividend for over 5 years, so it has already some track record.
JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

JBTM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
JBTM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-17.36%
EPS Next 2Y21.12%
EPS Next 3Y22.75%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (11/24/2025, 8:05:50 PM)

After market: 139.09 0 (0%)

139.09

+0.12 (+0.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)05-04 2026-05-04
Inst Owners92.99%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner Change3.95%
Market Cap7.23B
Revenue(TTM)3.26B
Net Income(TTM)-110.60M
Analysts80
Price Target153.82 (10.59%)
Short Float %5.7%
Short Ratio4.88
Dividend
Industry RankSector Rank
Dividend Yield 0.3%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-17.36%
Div Incr Years0
Div Non Decr Years4
Ex-Date08-18 2025-08-18 (0.1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.24%
Min EPS beat(2)14.08%
Max EPS beat(2)26.4%
EPS beat(4)3
Avg EPS beat(4)11.49%
Min EPS beat(4)-8.58%
Max EPS beat(4)26.4%
EPS beat(8)5
Avg EPS beat(8)4.11%
EPS beat(12)9
Avg EPS beat(12)6.09%
EPS beat(16)11
Avg EPS beat(16)6.44%
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.12%
Max Revenue beat(2)5.11%
Revenue beat(4)3
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)5.11%
Revenue beat(8)4
Avg Revenue beat(8)-1.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.62%
Revenue beat(16)5
Avg Revenue beat(16)-3.94%
PT rev (1m)4.87%
PT rev (3m)16.54%
EPS NQ rev (1m)0.66%
EPS NQ rev (3m)0.18%
EPS NY rev (1m)0%
EPS NY rev (3m)4.41%
Revenue NQ rev (1m)0.8%
Revenue NQ rev (3m)0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE 22.8
Fwd PE 18.59
P/S 2.22
P/FCF 26.43
P/OCF 20.47
P/B 1.64
P/tB N/A
EV/EBITDA 22.77
EPS(TTM)6.1
EY4.39%
EPS(NY)7.48
Fwd EY5.38%
FCF(TTM)5.26
FCFY3.78%
OCF(TTM)6.8
OCFY4.89%
SpS62.69
BVpS85.06
TBVpS-22.35
PEG (NY)1.29
PEG (5Y)44.04
Graham Number108.05
Profitability
Industry RankSector Rank
ROA -1.35%
ROE -2.5%
ROCE 2.39%
ROIC 1.95%
ROICexc 1.98%
ROICexgc 10.75%
OM 4.81%
PM (TTM) N/A
GM 35.8%
FCFM 8.4%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexgc growth 3Y-1.29%
ROICexgc growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 6.97
Debt/EBITDA 5.04
Cap/Depr 36%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 93.41%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 1.83
F-Score3
WACC8.89%
ROIC/WACC0.22
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.08%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%29.33%
EPS Next Y17.72%
EPS Next 2Y21.12%
EPS Next 3Y22.75%
EPS Next 5YN/A
Revenue 1Y (TTM)92.43%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%120.65%
Revenue Next Year113.32%
Revenue Next 2Y49.55%
Revenue Next 3Y33%
Revenue Next 5Y4.83%
EBIT growth 1Y-4.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year194.36%
EBIT Next 3Y56.52%
EBIT Next 5YN/A
FCF growth 1Y328.68%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y167.78%
OCF growth 3Y1.15%
OCF growth 5Y16.21%

JBT MAREL CORP / JBTM FAQ

What is the fundamental rating for JBTM stock?

ChartMill assigns a fundamental rating of 3 / 10 to JBTM.


What is the valuation status for JBTM stock?

ChartMill assigns a valuation rating of 3 / 10 to JBT MAREL CORP (JBTM). This can be considered as Overvalued.


Can you provide the profitability details for JBT MAREL CORP?

JBT MAREL CORP (JBTM) has a profitability rating of 3 / 10.


What is the valuation of JBT MAREL CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for JBT MAREL CORP (JBTM) is 22.8 and the Price/Book (PB) ratio is 1.64.


What is the earnings growth outlook for JBT MAREL CORP?

The Earnings per Share (EPS) of JBT MAREL CORP (JBTM) is expected to grow by 17.72% in the next year.